Oura, the company behind the Oura smart ring, has signed a definitive agreement to acquire Counsel Health, a startup that combines a medical AI chat service with its own staff of physicians. The deal was announced on November 10, 2026.
Oura is paying $625 million in cash, subject to purchase price adjustments. The announcement said the companies expect the deal to close before the end of the calendar year, once customary closing conditions are met. TechCrunch, reporting on the same day, said the deal was expected to close before the end of 2027.
Counsel's service will stay inside the Oura app, where members can already ask its AI medical questions and bring in a doctor when needed. Counsel will also keep working with its existing enterprise customers and sign new ones. Counsel founder and chief executive Muthu Alagappan will join Oura as chief clinical AI officer, along with Counsel's roughly 70 employees, TechCrunch reported, citing Bloomberg.
What Counsel Health built
Counsel describes itself as an AI-native primary care company. Patients start by chatting with its medical AI, which draws on connected medical records, past conversations, clinical guidelines and, for Oura users, data from the ring. At any point they can add one of Counsel's board-certified physicians to the conversation, who can diagnose conditions, prescribe medication and make referrals.
According to the announcement, the system runs on what Counsel calls a clinical AI harness that calls on specialised agents for tasks such as taking a medical history, retrieving guidelines, reviewing records and spotting emergencies. Its doctors work through an internal tool called the Clinician Cockpit, which summarises a patient's record and health trends and suggests next steps.
Counsel sells the service to health plans, health systems, consumer health companies and employers. In February it said its physicians covered nearly all 50 US states. Consumers can also use it directly: its website offers a free AI conversation and charges $29 to add a doctor.
“At Counsel, we’ve built medical AI around trust, safety and responsibility, keeping physicians in the loop for clinical decisions.”
Why Oura is buying
The two companies first teamed up in June 2026, when Counsel's service went live in the Oura app. In September Counsel said it had joined ACCESS, a Medicare model, to offer its chronic care service to Medicare beneficiaries. Oura said that among members who use Counsel and were surveyed, more than 90 percent said their ring data helped them get better care, and that patients who saw a Counsel physician rated the experience 4.6 out of 5.
Oura said it plans to build on the partnership across preventive care, acute care, and specialty and chronic care. Executive chairman David Shuman said the deal widens the company's addressable market and that Counsel's enterprise customers give Oura access to millions of people who do not own a ring.
The purchase also gives Oura a new line of business at a time when competition in smart rings is growing. TechCrunch noted that rivals such as RingConn and Ultrahuman have been pressuring the company, which has long led the category.
Oura's finances
Oura paired the deal with preliminary, unaudited results. Revenue for the quarter ended September 30, 2026, its fiscal fourth quarter, rose 153 percent from a year earlier to $533 million, and the company reported $87 million of adjusted EBITDA. For fiscal 2026 it reported revenue of about $1.75 billion, up 92 percent. Shuman said the company has more than six million members.
The acquisition comes a few weeks after Oura postponed its initial public offering indefinitely, citing uncertainty in the IPO market, according to TechCrunch. The company was valued at $11 billion after a $900 million funding round in October 2025.
The founder and the funding
Alagappan is a physician who previously worked as chief medical officer at Notable Health and as an attending physician at Massachusetts General Hospital and UCSF. He holds undergraduate and medical degrees from Stanford, where he published research on healthcare and artificial intelligence. Counsel's leadership team also includes chief medical officer Rishi Khakhkhar and chief technology officer Robert Christ.
Counsel raised a $25 million Series A about a year before the deal, co-led by Andreessen Horowitz and GV. TechCrunch cited a PitchBook estimate that the company had raised about $36 million in total. Neither company disclosed Counsel's revenue. Its February announcement of a place on the 2026 New York Digital Health 100 list, a ranking of health startups in the New York region, carried a New York dateline.




